Across 495 first-hand reports, people mentioned a side effect 18 times (about 4 per 100 reports). The most common: irritability, insomnia, headache. User reports show what people notice — they can't tell you whether Oxiracetam is safe for you.
“Oxi gave me a significant increase in focus, to the point where I could work for 2-3 hours without even checking facebook. / It also helped me with memory (was clearly retaining more info in both short-term and long-term).”
“I took 2-3 750 mg of Oxiracetam a day...Similarly, I felt nothing.”
“When dosed I feel stimulated and logical. It was great when taken during my statistics class. I actually made less simple calculation errors during math tests.”
“I haven't felt anything from Oxiracetam, in doses ranging from 100mg to 1.2g.”
“I got my oxi from there and was dosing it pretty well for a month. Nothing.”
Conclusion: This study enhances the understanding of the relative benefits and risks associated with various VaD treatments, providing a valuable reference for clinical decision-making.
Conclusion: Protocol Registration: PROSPERO (ID: CRD42019117178). Available online at: http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42019117178.
Conclusion: Conclusion: Our study demonstrated that ACEI inhibitors (Donepezil) and NMDA antagonists (Memantine), EGB761, and acupuncture are the ADL and BI, MoCA, and neurological function deficit medication/therapy, respectively, for patients with PSCI. Clinical Trial Registration: https://inplasy.com/inplasy-2022-11-0139/; Identifier: INPLASY2022110139.